Ajanta Pharma Schedules Board Meeting for Q2 and H1 Earnings
Ajanta Pharma Ltd 路 Intimation 路 30 Oct 2026, 5:30 am
Ajanta Pharma Schedules Board Meeting for Q2 and H1 Earnings Ajanta Pharma Limited informed stock exchanges that its Board of Directors will meet on 30th Oct'26. The board will consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended 30th Sep'26, pursuant to Regulation 29 of SEBI Listing Regulations.
Original exchange filing (PDF)
More announcements from Ajanta Pharma Ltd
- The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 16, 2026 for Aayush Agrawal, .... 路 17 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 09, 2026 for Aayush Agrawal, .... 路 09 Nov 2026
- Pls find enclosed Earnings Call Written Transcript 路 04 Nov 2026
- Pls find enclosed Audio recording of Earnings Call 路 30 Oct 2026
- Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 30 Oct 2026
- Pls find enclosed results for the quarter ended 30.09.2026. 路 30 Oct 2026
- Pls find enclosed Financial Results for the quarter ended 30.09.2026. 路 30 Oct 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 19, 2026 for Aayush Agrawal, trustee .... 路 21 Oct 2026
